NasdaqCM - Delayed Quote USD

Quantum BioPharma Ltd. (QNTM)

15.45
+1.70
+(12.36%)
At close: June 6 at 4:00:00 PM EDT
14.95
-0.50
(-3.24%)
After hours: June 6 at 7:51:44 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for QNTM

Recent News: QNTM

View More
Quantum BioPharma Clarifies It Has Not Changed Its Name

Quantum BioPharma Clarifies It Has Not Changed Its Name
GlobeNewswire 3 days ago
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
GlobeNewswire 7 days ago
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.
GlobeNewswire 8 days ago
Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome
GlobeNewswire 9 days ago
Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets

Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets
GlobeNewswire 16 days ago
Sidoti Events, LLC's Virtual May Micro-Cap Conference

Sidoti Events, LLC's Virtual May Micro-Cap Conference
ACCESS Newswire 17 days ago
Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis
GlobeNewswire 17 days ago
Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference
GlobeNewswire 21 days ago
Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis
GlobeNewswire 25 days ago
Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
GlobeNewswire last month
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time
GlobeNewswire last month
View More

Related Tickers

INM InMed Pharmaceuticals Inc.
2.8700
-9.18%
 
IMCC IM Cannabis Corp.
2.7600
-3.16%
 
IXHL Incannex Healthcare Inc.
0.1793
+0.17%
 
RGC Regencell Bioscience Holdings Limited
685.85
+7.16%
 
UPC Universe Pharmaceuticals INC
4.2900
+2.14%
 
CGC Canopy Growth Corporation
1.7000
+24.09%
 
BFRI Biofrontera Inc.
0.6000
+0.08%
 
ELTP Elite Pharmaceuticals, Inc.
0.5800
+3.57%
 
PTPI Petros Pharmaceuticals, Inc.
0.0334
+4.70%
 
ACB Aurora Cannabis Inc.
5.72
+5.73%